Table 2.

The clinicopathologic characteristics and the IDO expressions in diffuse large B-cell lymphomas.

Histologic Type	Age	Sex	Site of Involvement	IDO
Diffuse Large B-cell Lymphoma, NOS
Germinal Center B-cell	42	M	Nasal cavity	score 3
	65	M	Nasal cavity	score 1
	10	M	Uvula, palatine tonsil	score 2
	81	F	Femur, brain	score 0
	59	F	Nasal cavity	score 0
	80	M	Testis	score 0
Activated B-cell	56	M	Inguinal lymph node	score 3
	42	F	Palatine tonsil	score 2
	66	M	Testis	score 2
	47	M	Palatine tonsil	score 0
	66	F	Axillary LN	score 2
	55	M	Palatine tonsil	score 2
	62	M	Testis	score 2
	54	M	Inguinal LN	score 2
	67	M	Palatine tonsil	score 4
	74	M	Heart	score 0
	67	M	Supraclavicular LN	score 0
	50	M	Palatine tonsil	score 1
	70	M	Nasal cavity	score 2
	54	F	Intestine, appendix, omentum, LN	score 0
	72	M	Stomach, large intestine, LN	score 2
	48	M	Cervical LN	score 0
	75	F	Small intestine	score 3
	70	M	Small intestine, appendix	score 4
	84	F	Nasal cavity	score 1
	70	M	Testis	score 2
T-cell/histiocyte–Rich Large B-cell Lymphoma	72	M	Neck, axillary LN	score 2
Primary DLBCL of the CNS	79	F	Brain	score 0
	78	F	Brain	score 0
	60	F	Brain	score 0
	78	M	Brain	score 0
Primary Cutaneous DLBCL, Leg type	77	F	Skin, upper arm and low leg	score 4
EBV-Positive DLBCL, NOS	62	M	Cervical LN	score 4
	86	F	Axillary LN	score 2

* LN: lymph node, DLBCL: diffuse large B-cell lymphoma, CNS: central nervous system, EBV: Epstein-Barr virus, NOS: not otherwise specified.